Clinical Trials Logo

Malignant Neoplasm clinical trials

View clinical trials related to Malignant Neoplasm.

Filter by:

NCT ID: NCT04361552 Withdrawn - Clinical trials for Coronary Artery Disease

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Start date: April 7, 2020
Phase: Phase 3
Study type: Interventional

This phase III trial compares the effect of adding tocilizumab to standard of care versus standard of care alone in treating cytokine release syndrome (CRS) in patients with SARS-CoV-2 infection. CRS is a potentially serious disorder caused by the release of an excessive amount of substance that is made by cells of the immune system (cytokines) as a response to viral infection. Tocilizumab is used to decrease the body's immune response. Adding tocilizumab to standard of care may work better in treating CRS in patients with SARS-CoV-2 infection compared to standard of care alone.

NCT ID: NCT04360993 Completed - Clinical trials for Head and Neck Cancer

Role of PET/MRI in Head and Neck Cancer

Start date: April 12, 2016
Phase:
Study type: Observational

Study aim was to investigate the diagnostic role of Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) in head and neck cancer.

NCT ID: NCT04292769 Recruiting - Malignant Neoplasm Clinical Trials

Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Start date: January 21, 2020
Phase: Phase 3
Study type: Interventional

1. Screening stage 2. Evaluation of disease 3. Grouping of patients 4. Infusion of cells 5. Surveillance of adverse effect

NCT ID: NCT04278534 Terminated - Malignant Neoplasm Clinical Trials

Virtual Reality for the Education of Cancer Patients Undergoing Radiation Therapy

Start date: May 28, 2020
Phase: N/A
Study type: Interventional

This trial studies the use of virtual reality as an educational tool for cancer patients undergoing radiation therapy. The purpose of the study is to learn about virtual reality education (VERT) and if it may be able to help people who are planning to receive radiation therapy. Patient education using virtual reality may result in better understanding and/or decreased anxiety in patients receiving radiation therapy.

NCT ID: NCT04266522 Completed - Malignant Neoplasm Clinical Trials

Medical Physics Direct Patient Care for the Improvement of Patient Understanding of Care

Start date: January 16, 2020
Phase: N/A
Study type: Interventional

This phase II trial studies how well medical physics direct patient care works in improving patients' understanding of their cancer treatment. Providing direct physicist-patient interactions and answering patients' questions about their cancer treatment may help patients to understand the care and therefore reduce anxiety and distress during treatment.

NCT ID: NCT04239976 Completed - Malignant Neoplasm Clinical Trials

Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain

Start date: April 4, 2019
Phase: N/A
Study type: Interventional

This trial studies how well scrambler therapy works in reducing chemotherapy-induced neuropathic pain in patients with cancer. Scrambler therapy is a type of treatment that uses electrodes placed on the skin. Electricity is carried from the electrodes through the skin and blocks the pain.

NCT ID: NCT04185935 Recruiting - Malignant Neoplasm Clinical Trials

Molecular Genetics Studies of Cancer Patients and Their Relatives

Start date: April 18, 1997
Phase:
Study type: Observational

This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.

NCT ID: NCT04185337 Active, not recruiting - Malignant Neoplasm Clinical Trials

Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes

Start date: January 26, 2021
Phase: Early Phase 1
Study type: Interventional

This early phase I trial studies how well ultrasound-guided photoacoustic imaging works in telling the difference between healthy and cancerous inguinal (groin) lymph nodes and how well it can detect certain features of lymph nodes, including size and shape in patients with cancer. Ultrasound-guided photoacoustic is a non-invasive imaging method that can detect and display characteristics of lymph nodes based on the level of oxygen in the cells. This imaging method may provide more accurate tumor staging and prevent unnecessary surgical interventions.

NCT ID: NCT04181463 Not yet recruiting - Malignant Neoplasm Clinical Trials

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Start date: December 5, 2024
Phase: N/A
Study type: Interventional

The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.

NCT ID: NCT04160390 Recruiting - Malignant Neoplasm Clinical Trials

Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant

Start date: November 13, 2018
Phase:
Study type: Observational

This trial uses blood samples to understand how patients' bodies process and respond to a drug called cyclophosphamide given after a donor stem cell transplant. Identifying biomarkers (molecules that can indicate normal or abnormal processes) may help researchers develop a blood test that can be used to predict how well patients will process and respond to cyclophosphamide.